نتائج البحث - "Patient‐Reported Outcomes·"

1

The role of patient-reported outcomes in reimbursement decisions and drug innovation in Italy

المؤلفون: Francesco Malandrini, Cesare Borroni, Michela Meregaglia, Massimiliano Sarra, Oriana Ciani

المصدر: Global & Regional Health Technology Assessment. 10:12-17

مصطلحات موضوعية: INNOVATIVENESS, EUROPEAN PUBLIC ASSESSMENT REPORTS, Health Policy, PATIENT-REPORTED OUTCOMES, PATIENT-REPORTED OUTCOME MEASURES, EUROPEAN PUBLIC ASSESSMENT REPORTS, INNOVATIVENESS, ITALIAN DRUG AGENCY, PATIENT-REPORTED OUTCOMES, PATIENT-REPORTED OUTCOME MEASURES, REIMBURSEMENT, ITALIAN DRUG AGENCY, REIMBURSEMENT

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b594a280fb45a8c8dc438ce11ae748a8
https://doi.org/10.33393/grhta.2023.2514

2

Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies

المساهمون: Institut Català de la Salut, [Mesa RA] Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA. [Hudgens S, Floden L] Clinical Outcomes Solutions, Tucson, Arizona, USA. [Harrison CN] Guy's and St. Thomas' NHS Foundation Trust, London, UK. [Palmer J] Mayo Clinic, Phoenix, Arizona, USA. [Gupta V] University Health Network, University of Toronto, Toronto, Ontario, Canada. [Fox ML] Servei d’Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Mesa, R A, Hudgens, S, Floden, L, Harrison, C N, Palmer, J, Gupta, V, McLornan, D P, McMullin, M F, Kiladjian, J-J, Foltz, L, Platzbecker, U, Fox, M L, Mead, A J, Ross, D M, Oh, S T, Perkins, A, Leahy, M F, Deheshi, S, Donahue, R, Klencke, B J & Verstovsek, S 2023, ' Symptomatic benefit of momelotinib in patients with myelofibrosis: results from the SIMPLIFY phase III studies ', Cancer Medicine . https://doi.org/10.1002/cam4.5799
Scientia

مصطلحات موضوعية: Cancer Research, Otros calificadores::/uso terapéutico [Otros calificadores], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], myelofibrosis, momelotinib, Other subheadings::Other subheadings::/drug therapy [Other subheadings], JAK inhibitor, Oncology, Hemic and Lymphatic Diseases::Hematologic Diseases::Bone Marrow Diseases::Myeloproliferative Disorders::Primary Myelofibrosis [DISEASES], patient-reported outcomes, Mielofibrosi - Tractament, symptoms, enfermedades hematológicas y linfáticas::enfermedades hematológicas::enfermedades de la médula ósea::trastornos mieloproliferativos::mielofibrosis primaria [ENFERMEDADES], Radiology, Nuclear Medicine and imaging, Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors::Janus Kinase Inhibitors [CHEMICALS AND DRUGS], Other subheadings::/therapeutic use [Other subheadings], Proteïnes quinases - Inhibidors - Ús terapèutic, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas::inhibidores de las cinasas Janus [COMPUESTOS QUÍMICOS Y DROGAS]